Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 5Lung Neoplasms 5Melanoma 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Lymphoma 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Unresectable or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Microsatellite Instability 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Glioma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Cytopenia 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1

Interventions

parsaclisib 1epacadostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unresectable or Metastatic Solid Tumors × epacadostat × Clear all
NCT03589651 2023-02-21

INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors

Incyte Corporation

Phase 1 Completed
83 enrolled
Other solid neoplasm

Unresectable or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡